Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
2.74
0.03 (1.11%)
At close: Sep 26, 2025, 3:59 PM
2.76
0.71%
After-hours: Sep 26, 2025, 07:54 PM EDT
Akebia Therapeutics Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License Collaboration And Other Revenue Revenue | 2.01M | 1.54M | 4.57M | 1.84M | 2.44M | 1.6M | 4.89M | 1.93M | 14.13M | 5.3M | 5.71M | 6.72M | 83.06M | 20.25M | 29.13M | 12M | 19.95M | 21.9M | 22.09M | 25.6M | 59.45M | 59.27M | 40.64M | 30M | 10M | 23.11M | 53.03M |
| License Collaboration And Other Revenue Revenue Growth | +30.16% | -66.16% | +148.69% | -24.72% | +52.63% | -67.33% | +153.68% | -86.36% | +166.69% | -7.28% | -15.02% | -91.90% | +310.13% | -30.48% | +142.70% | -39.85% | -8.87% | -0.90% | -13.68% | -56.94% | +0.30% | +45.84% | +35.45% | +200.04% | -56.73% | -56.42% | n/a |
| Product Revenue | 60.46M | 55.79M | 85.58M | 35.59M | 41.21M | 31.01M | 93.23M | 40.12M | 42.24M | 34.83M | 49.68M | 42.24M | 43.7M | 41.45M | 42.1M | 36.75M | 32.96M | 30.41M | 34.6M | 34.39M | 30.7M | 29.21M | 28.91M | n/a | n/a | n/a | n/a |
| Product Revenue Growth | +8.37% | -34.81% | +140.44% | -13.63% | +32.89% | -66.74% | +132.39% | -5.03% | +21.29% | -29.89% | +17.61% | -3.35% | +5.44% | -1.54% | +14.54% | +11.51% | +8.39% | -12.13% | +0.62% | +12.04% | +5.09% | +1.02% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 26.55M | 25.74M | 27.68M | 26.52M | 27.68M | 26.15M | 26.29M | 22.71M | 27.04M | 25.22M | 29.91M | 31.66M | 33.7M | 45.02M | 44.8M | 47.23M | 42.55M | 42.02M | 40.31M | 40.88M | 36.53M | 38.66M | 44.92M | 34.18M | 36.96M | 34.29M | 55.12M | 10.38M | 12.54M | 9.02M | 7.57M | 6.75M | 6.91M | 5.79M | 6.14M | 4.94M | 5.31M | 5.81M | 7.51M | 3.89M | 3.71M | 3.39M |
| Selling, General, and Administrative Revenue Growth | +3.16% | -6.98% | +4.37% | -4.20% | +5.85% | -0.54% | +15.76% | -16.00% | +7.20% | -15.67% | -5.54% | -6.05% | -25.14% | +0.47% | -5.13% | +11.00% | +1.24% | +4.25% | -1.39% | +11.92% | -5.52% | -13.93% | +31.42% | -7.53% | +7.79% | -37.79% | +431.13% | -17.23% | +38.94% | +19.25% | +12.14% | -2.27% | +19.30% | -5.79% | +24.27% | -6.91% | -8.60% | -22.63% | +93.18% | +4.88% | +9.32% | n/a |
| Research and Development Revenue | 11.01M | 9.75M | 11.79M | 8.49M | 7.25M | 9.37M | 9.47M | 13.33M | 20.2M | 19.69M | 31.9M | 27.35M | 26.03M | 43.83M | 29.56M | 40.47M | 37.21M | 40.61M | 37.58M | 46.86M | 52.82M | 81.23M | 80.41M | 74.51M | 85.69M | 82.35M | 87.11M | 70.63M | 71.92M | 61.4M | 68.38M | 58.71M | 43.75M | 60.05M | 33.44M | 31.24M | 30.88M | 20.23M | 12.54M | 15.79M | 7.18M | 7.5M |
| Research and Development Revenue Growth | +12.91% | -17.24% | +38.87% | +17.09% | -22.62% | -1.11% | -28.94% | -34.00% | +2.60% | -38.30% | +16.65% | +5.08% | -40.62% | +48.30% | -26.97% | +8.75% | -8.36% | +8.07% | -19.80% | -11.29% | -34.98% | +1.02% | +7.92% | -13.05% | +4.06% | -5.47% | +23.33% | -1.78% | +17.12% | -10.20% | +16.47% | +34.19% | -27.14% | +79.60% | +7.03% | +1.17% | +52.59% | +61.38% | -20.59% | +119.86% | -4.30% | n/a |